Product NDC: | 0173-0453 |
Proprietary Name: | FLONASE |
Non Proprietary Name: | Fluticasone Propionate |
Active Ingredient(s): | 50 ug/1 & nbsp; Fluticasone Propionate |
Administration Route(s): | NASAL |
Dosage Form(s): | SPRAY, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0453 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020121 |
Marketing Category: | NDA |
Start Marketing Date: | 19941108 |
Package NDC: | 0173-0453-01 |
Package Description: | 1 BOTTLE in 1 CARTON (0173-0453-01) > 120 SPRAY, METERED in 1 BOTTLE |
NDC Code | 0173-0453-01 |
Proprietary Name | FLONASE |
Package Description | 1 BOTTLE in 1 CARTON (0173-0453-01) > 120 SPRAY, METERED in 1 BOTTLE |
Product NDC | 0173-0453 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fluticasone Propionate |
Dosage Form Name | SPRAY, METERED |
Route Name | NASAL |
Start Marketing Date | 19941108 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | FLUTICASONE PROPIONATE |
Strength Number | 50 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |